Company news
NIOX Group PLC news in 2019
NIOX Group PLC's news releases, calls and decks from 2019, newest first.
Update on Licensing Agreement with BeyondAir Inc.
December 19, 2019
Circassia Announces Board Changes
December 5, 2019
US launch of Duaklir at CHEST 2019
October 21, 2019
Interim Results for Six Months Ended 30 June 2019
September 26, 2019
Notice of Results and Appointment of Joint Broker
September 12, 2019
Appointment of Jonathan Emms as COO
August 12, 2019
Price Monitoring Extension
June 17, 2019
Publication of Tudorza Phase IV ASCENT in JAMA
May 8, 2019
FDA approval of Duaklir for treatment of COPD
April 1, 2019
FDA website posts Duaklir NDA approval
March 29, 2019
Circassia announces FDA approval of Tudorza sNDA
March 29, 2019
Notice of Results
February 8, 2019
Successful FDA Presubmission Meeting for AirNOvent
February 4, 2019
Admission to AIM
February 4, 2019
Commercial rights acquired from AIT Therapeutics
January 24, 2019
General Meeting Business Update
January 4, 2019